Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$38.35 0.40 (1.05%)
2/9/2010 3:59 PM

Bio-Reference Laboratories, Inc. (BRLI)

CAPS Rating:
*****

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BRLI

Add Stock to Watchlist

What the Community Thinks

Total Members

189 Outperforms
9 Underperforms
 

All-Stars

66 Outperforms
0 Underperforms
 

Wall Street

1 Outperforms
1 Underperforms
 

Members bullish on BRLI are also bullish on:

Members bearish on BRLI are also bearish on:

Ticker Tags

Small Cap (1645), Defensive (1457), Research (13), Healthcare (711), Growth (1902), Healthcare Providers and Services (125)
Suggest a tag

Bio-Reference Laboratories, Inc. At A Glance

Current Price: $38.35
Last Trade Time: 2/9/2010 3:59 PM
Open: $0.00
Previous Close: $37.95
Daily Range: $37.90 - $38.56
52-Week Range: $20.28 - $40.87
Volume: 87,632
Market Cap: $531.76M
P/E Ratio: 24.02
Compare Our Special Broker Offers!

Stock Trends

BRLI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

6

Bio-Reference Laboratories, Inc. (BRLI)

Avatar thestinkyfeet (97.89) Submitted: 8/02/08 12:58 PM

The reasoning behind the selection of this stock, and a board on which to discuss the stock, or whatever else you like, can be found on the MF Stinky Feet discussion board at http://boards.fool.com/Messages.asp?mid=26829411&bid=119057&days=7 . Hope to see you there.

Replies: 2 | Reply | Permalink

Top Bear Pitch

Recs

2

Bio-Reference Laboratories, Inc. (BRLI)

Avatar ac11166 (< 20) Submitted: 8/29/06 4:26 PM

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Recs

0

 (BRLI)

Avatar TMFQue (98.06) Submitted: 2/01/10 11:35 AM : Outperform Start Price: $37.64 BRLI Score: 3.28

Stocks 360

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRLI)

Avatar cfackler (98.59) Submitted: 1/08/10 9:27 AM : Outperform Start Price: $38.74 BRLI Score: 4.85

This pick based solely on passage of the healthcare bill. Bill passes, millions of new tests will be ordered and this company will most likely prosper; no healthcare bill, business as usual and this company will still do just fine. (Based on the performance and numbers I've seen to date...)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRLI)

Avatar REIN (95.68) Submitted: 11/17/09 7:41 PM : Outperform Start Price: $31.84 BRLI Score: 24.08

Small cap stock with too good to be true earning performance, maybe that's a warning sign?. While sales and earnings haven't been deterred by this economic downturn, the P/E ratio has been reduced from about 30 to about 20. Expect this company to keep growing at 20%, perhaps P/E will creep back up again, maybe they'll get bought out by a bigger player.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRLI)

Avatar predfern (< 20) Submitted: 11/06/09 11:50 PM : Outperform Start Price: $32.56 BRLI Score: 18.46

fast growing clinical lab

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRLI)

Avatar HLChin (94.64) Submitted: 10/23/09 3:28 PM : Outperform Start Price: $34.55 BRLI Score: 11.61

I put this on CAPs as a test because I believe that CEOs who put better science and better service as primary goals will succeed in a stock market filled with bean-counters. And that profitability and growth will follow
- CEO Marc D. Grodman holds 11% of the stock
- Differentiated diagnostic tests
- $15m cash, $30m debt but with 20 times interest coverage

Risks - Medicare provided 25% of revenue

"Grow or die"

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWMBlair 69.55 02/21/08 Outperform NS $28.92+32.63%-17.83%+50.46
TrackJimCramer < 20 12/20/06 Underperform 3W $22.98+66.88%-19.90%-86.79

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 562ms